Phosfood Liquid
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
10 Drop(s)
Serving Size
120
Servings
Mineral
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
40 mg
(3% DV)
✅ Within RDA (0.1× RDA of 700 mg)
📚 12 studies (Tier A: 0, B: 3)
Other Ingredients
Water
Phosphoric Acid
Inositol
Riboflavin
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (89% of products)
Nutrient (76% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Suggested use: Ten drops in water, three times per day, or as directed.
⚠️ Warnings & Precautions
Warning: If spilled, staining may occur.
Keep out of reach of children.
🧪 Formulation Notes
Phosphorus support
GF (gluten free)
Additional Information
Whole Food Supplements Since 1929
Product Details
UPC / SKU
8 12122 01156 3
DSLD Entry Date
2025-09-25
Product Type
Mineral
Form
Liquid
Brand
SP Standard Process
DSLD ID
340271
Data Updated
2026-04-11
Research Evidence
46
Research Sources
55
Avg Quality Score
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Compare Similar Products
Super Phosphozyme Liquid
Biotics Research Corporation
100
Ultimate Phosphorus Concentrate
Complete H2O Minerals
100
AdenoPlus
Nutrasal
100
Ionic Phosphorus 50,000 PPM
Good State
100
Phosfood Liquid
SP Standard Process
100